Back to search

Article

Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemia

2023-03-01

Abstract excerpt

<h4>ABSTRACT</h4> Elimination of drug-resistant leukemia stem cells (LSCs) represents a major challenge to achieve a cure in acute myeloid leukemia (AML). Although AML blasts generally retain high levels of surface CD38 (CD38 pos ), the presence of CD34 and lack of CD38 expression (CD34 pos CD38 neg ) are immunophenotypic features of both LSC-enriched AML blasts and normal hematopoietic stem cells (HSCs). We r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
91528671-c96e-5f9c-968f-b5defe3e361c
DOI
10.1101/2023.02.27.530273
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Leveraging IFNγ/CD38 regulation to unmask and target leukemia stem cells in acute myelogenous leukemiaDOI 10.1101/2023.02.27.530273
Select a neighboring publication to make it the new centre.